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Abstract
The comorbidities affect the course of pancreatitis significantly; however, this effect has not been evaluated from the
perspective of genetic component.
The objective of the research was to analyse concomitant chronic diseases as potential risk factors for edematous pancreatitis
considering genetic predictors.
Materials and methods. The epidemiological analysis of comorbidities (cholelithiasis, urolithiasis, ischemic heart disease,
past viral infection) as risk factors for edematous pancreatitis was performed. Polymorphic variants of the IL-4 (rs 2243250)
gene being identified in 123 patients and 40 healthy individuals were also involved.
Results. In patients with edematous pancreatitis, urolithiasis was observed more frequently than in the control group - by
37.30% (χ2=18.62, p<0.001). The presence of cholelithiasis insignificantly increases the risk of edematous pancreatitis in
the future (RR-1.156; 95% CI: 0.972-1.374). The presence of urolithiasis increased the risk of edematous pancreatitis twofold
(RR-2.039; 95% CI: 1.346-3.090; p<0.05).
Conclusions. 1. Cholelithiasis increases the probability of developing edematous pancreatitis in carriers of the mutant
T-allele of the IL-4 gene by 3.7 times (RR=3.69; OR=10.13; 95% CI OR: 3.17-32.42; p<0.05). 2. In the C-allele carriers of the
IL-4 (C-590T) gene, the risk of developing acute pancreatitis is twice higher in the presence of urolithiasis or ischemic heart
disease, and almost five times higher in case of past viral infection (p<0.05).
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Problem statement and analysis of the
resent research
Numerous medical studies have found more than 200 causes
of pancreatitis; alcohol and cholelithiasis have been recog-
nized as the most significant (classificational) ones [1-4, 6-9,
11].
The multisystem manifestations of organ as well as system
disintegration being connected with disorders in enterohepatic
circulation of free fatty acids, bile passage in the hepatobil-
iary system, the development of gallstone disease (GSD),
cardiovascular diseases (atherosclerosis, ischemic heart dis-
ease (IHD), hypertension), urinary disorders (urinary stone
disease (USD), inflammatory diseases), metabolic disorders
(diabetes mellitus) are prevalent in the pathogenesis of pan-
creatitis. However, they have not been evaluated from the per-
spective of genetic component – polymorphisms in candidate
genes associated with the development of pancreatitis (PRSS1
(rs111033565), SPINK1 (ID 6690), CFTR (rs113993960))
and genes regulating the inflammatory response to the devel-
opment of the latter (IL- 4 (rs 2243250), TNF-α (rs1800629)),
as additional possible risk factors for acute pancreatitis (AP),
and exacerbation of chronic pancreatitis (ECP).
The objective of the research was to analyse concomi-
tant chronic diseases as potential risk factors for edematous
pancreatitis considering genetic predictors.
1. Materials and methods
The study involved 123 patients with AP and ECP (edematous
form), who were treated in Chernivtsi Regional Emergency
Hospital (Chernivtsi, Ukraine). The diagnosis of AP and ECP
was made on the basis of the existing national and European
Societies’ recommendations on the diagnosis and treatment
of AP [10, 12]. All the patients signed an informed consent to
participate in the research and they underwent a complex of
examinations: clinical, laboratory and instrumental ones ac-
cording to the protocol recommendations. Among the patients
there were 23 (18.7%) women and 100 (81.3%) men. The pa-
tients’ average age was 45.1±5.19 years for males, 53.2±7.07
years for females (from 23 to 77). The control group included
40 apparently healthy individuals of corresponding sex and
age.
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Molecular genetic studies, which included the determi-
nation of polymorphic variants of the IL-4 (C-590T) gene,
were performed at the laboratory of the Reference Centre for
Molecular Diagnostic, Ministry of Public Health of Ukraine
(Kyiv, Ukraine) and the laboratory of the Department of Med-
ical Biology and Genetics of the Bukovinian State Medi-
cal University (Chernivtsi, Ukraine). The polymorphic vari-
ants of the analysed IL-4 (C-590T) gene were studied using
the polymerase chain reaction (PCR) method be means of
oligonucleotide primers synthesized in Metabion company
(Germany) according to the modified protocols [5]. The
amplification products of DNA fragments of the gene were
thereafter digested with restriction endonuclease (Thermo
Scientific, USA): enzyme AvaII – for the IL-4 gene. The ob-
tained fragments were analysed by agarose gel electrophoresis
and stained with ethidium bromide, molecular weight marker
GeneRuler 50 bp (DNA Ladder, Thermo Scientific, USA),
with further visualization using transilluminator.
The correspondence of the genotype distribution of gene
polymorphism to Hardy-Weinberg law in the control group
was tested with the chi-square test with 1 degree of freedom,
without Yates’ correction; the difference in the genotype distri-
bution between the control group and the patients was tested
using the chi-square test with 2 degrees of freedom.
2. Results and Discussion
The epidemiological analysis of comorbidities, metabolic
changes, parameters of the hepato-pancreato-biliary system
function, inflammatory markers as risk factors for edematous
pancreatitis considering polymorphic variants of the IL-4 (rs
2243250) gene was performed.
The incidence of the most frequent comorbidities as risk
factors for edematous pancreatitis is presented in Table 1.
In patients with edematous AP, USD occurred significantly
more often than in the control group - by 37.30% (χ2=18.62,
p<0.001). Ultrasonography of the liver and biliary tract
showed that GSD was found more frequently in patients with
AP; however, there was no statistically significant difference
in the index distribution (χ2=1.79; p>0.05).
Atherosclerotic changes in the mesenteric vessels as one
of the manifestations of IHD are the triggers of developing
trophic changes in the digestive organs including the pancreas
and, consequently, the occurrence of inflammation and its
chronicity, as well as the development of exocrine pancreatic
insufficiency. However, chronic IHD occurred equally often
in patients with pancreatitis (36.58%) and in the control group
(40.0%, p>0.05; Table 1).
A varied virus flora can be an etiologic factor of inflamma-
tion development in the pancreas. The anamnestic indications
of past viral infection in the last 6 months were registered
in 31.71% of patients with AP and 22.5% of patients of the
control group (Table 1), which, however, did not differ statis-
tically significant between the groups (p>0.05).
The Wirsung duct permeability dysfunction being the
main cause of pancreatitis, its chronicity and exacerbations
Table 1. Concomitant diseases in patients of the studied
groups
Nosology Main group,
n=123 (%)
Control
group, n=40
(%)
χ2; p
GSD 31 (25.20) 6 (15.0) χ2=1.79;
p>0.05
USD 92 (74.80) 15 (37.50) χ2=18.62;
p<0.001
IHD 45 (36.58) 16 (40.0) χ2<1.0;
p>0.05
Viral infec-
tion
39 (31.71) 9 (22.50) χ2=1.23;
p>0.05
Note.
DSG - gallstone disease;
USD - urinary stone disease;
IHD - ischemic heart disease.
development, may be caused by functional or organic changes
in the biliary tract. These are often observed in cholelithiasis,
which together with urolithiasis may indicate the individual
characteristics of mineral metabolism and predisposition to
stone formation in hollow organs. The analysis of our epi-
demiological statistics data showed that GSD presence in-
significantly increases the risk of edematous pancreatitis in
the future (RR-1.156; 95% CI: 0.972-1.374; Table 2).
The presence of USD increases the risk of edematous pan-
creatitis twofold (RR-2.039; 95% CI: 1.346-3.090; p<0.05).
However, the presence of IHD as well as a positive history
of viral diseases (RR-1.446; 95% CI: 0.769-2.719; p>0.05;
Table 2) did not increase the probability of AP development
(RR-0.936; 95% CI: 0.599-1.462; p>0.05). In our opinion,
the peculiarities of the realization of the inflammatory process
in the pancreas provided by genetically caused high or low
levels of production of basic inflammatory mediators, includ-
ing IL-4 being one of the main anti-inflammatory interleukins,
which, moreover, is associated with T-helper-2-type of inflam-
matory response are interesting in the scientific aspect.
When determining the anamnestic peculiarities in patients
with edematous pancreatitis and genetically caused high/low
production of IL-4, GSD was statistically more often observed
in carriers of mutant T-allele compared to those with C-allele
(by 29.28%) (χ2=17.54, p¡0.001; Table 3). USD, IHD and
past viral infections were significantly more often observed
in C-allele carriers compared to owners of T-allele of the IL-
4 gene - by 23.64% (χ2=5.79; p=0.016), 23.44% (χ2=4.57;
p=0.033) and 28.46% (χ2=7.11; p=0.008), respectively (Table
3). There was found a relatively strong correlation (φ=0.417;
Table 4) between GSD presence and pancreatitis development
in carriers of the T-allele of the IL-4 gene. In addition, GSD
increased the risk of edematous pancreatitis approximately by
4 times in patients with the low production of IL-4, caused
by the mutation in the promoter region of the IL-4 gene at
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position - 590 (RR-3.686; 95% CI: 2.199-6.178; Table 5).
There was a medium direct positive correlation between USD
and the development of pancreatitis (Sp-0.249), IHD and
AP (φ -0.213), viral flora and AP (φ -0.271) in homozygous
carriage of the dominant C-allele of the IL-4 gene (Table 4).
USD, IHD and viral infection did not increase the risk of AP
appearance in carriers of mutation in the promoter region of
the IL-4 gene at position - 590 (RR-0.454; 95% CI: 0.266-
0.776), (RR-0.435; 95% CI: 0.206-0.916) and (RR-0.277;
95% CI: 0.105-0.723), respectively (Table 5). Thus, the
presence of USD was the risk factor of edematous pancreatitis
development, whereas, the presence of cholelithiasis, past
viral infection, or atherosclerosis of the vessels with clinical
manifestation in the form of IHD did not affect the risk of
inflammatory process in the pancreas. Depending on the
genetically inherited high or suppressed production of IL-4
it has been found that in the presence of mutant thymine in
the promoter region of the IL-4 gene at position - 590 (C-
590T) associated with the reduction in the level of coded
anti-inflammatory cytokine production, the realization of the
inflammatory process in the pancreas is possible if GSD is
Table 2. Epidemiological assessment of comorbidities as
risk factors for edematous pancreatitis in the investigated
population
Sign GSD USD IHD Viral
infection
EER 0.842 0.746 0.365 0.317
CER 0.729 0.366 0.39 0.22
RR 1.156 2.039 0.936 1.446
S (RR) 0.0887 0.212 0.228 0.322
95% CI
RR
0.972-
1.374
1.346-
3.090
0.599-
1.462
0.769-
2.719
Se 0.254 0.862 0.742 0.816
Sp 0.854 0.448 0.238 0.271
OR 1.986 5.092 1.902 1.654
S (OR) 0.487 0.383 0.419 0.423
95% CI
OR
0.765-
5.158
2.401-
10.795
0.836-
4.325
0.722-
3.790
p >0.05 <0.05 >0.05 >0.05
Note.
DSG - gallstone disease;
USD - urinary stone disease;
IHD - ischemic heart disease;
EER - experimental event rate;
CER - control event rate;
RR - relative risk;
S (RR) - standard error of the relative risk;
95% CI RR - 95% confidence interval of the relative risk;
Se - sensitivity;
Sp - specificity;
OR - odds ratio;
S (OR) - standard error of the odds ratio;
95% CI OR - 95% confidence interval of the odds ratio.
Table 3. Concomitant diseases depending on the allelic state
of the IL-4 gene in patients with edematous pancreatitis
Nosology Carriers of
T-allele (52
alleles),
n=26 (%)
Carriers of
C-allele
(150 alleles),
n=75 (%)
χ2; p
GSD 9 (34.61) 4 (5.33) χ2=17.54;
p<0.001
USD 15 (57.69) 61 (81.33) χ2=5.79;
p=0.016
IHD 5 (19.23) 32 (42.67) χ2=4.57;
p=0.033
Viral infec-
tion
3 (11.54) 30 (40.0) χ2=7.11;
p=0.008
Note.
DSG - gallstone disease;
USD - urinary stone disease;
IHD - ischemic heart disease.
present without involving other risk factors. Cholelithiasis
increased the probability of developing edematous pancreatitis
in carriers of the mutant T-allele of the IL-4 gene by 3.7 times.
For clinical manifestation of AP in the owners of dominant
cytosine in the promoter region of the IL-4 gene at position -
590 associated with high production of IL-4, the risk factors
that reflect vascular and metabolic disorders in the body or are
indicative of some etiological factor action are needed. Thus,
the presence of USD or IHD increased the risk of AP in the
C-allele carriers of the IL-4 (C-590T) gene twofold. Past viral
infection increased AP probability in the C-allele carriers of
the IL-4 gene by approximately five times.
3. Conclusions
• In the presence of mutant thymine in the promoter re-
gion of the IL-4 gene at position - 590 (C-590T) as-
sociated with the reduction in the level of coded anti-
inflammatory cytokine production, the realization of
the inflammatory process in the pancreas is possible if
GSD is present without involving other risk factors.
• Cholelithiasis increases the probability of developing
edematous pancreatitis in carriers of the mutant T-allele
of the IL-4 gene by 3.7 times (RR=3.69; OR=10.13;
95% CI OR: 3.17-32.42; p¡0.05).
• In the C-allele carriers of the IL-4 (C-590T) gene, the
risk of developing acute pancreatitis is twice higher in
the presence of USD or IHD, and almost five times
higher in case of past viral infection (p<0.05).
4. Prospects for further research
The analysis of inflammatory markers as risk factors for
chronic pancreatitis providing genetic determination of IL-4
production is promising.
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Table 4. Correlations matrix between indices of comorbidity and edematous pancreatitis development in carriers of T-allele of
the IL-4 gene
Factor Statistical criteria of assessing the relation between factors
Sp χ2 TSFET φ ; connection
strength
GSD -0.311 19.315* 0.00000* 0.417; relatively
strong
USD 0.249 7.798* 0.01079* 0.249; average
IHD 0.186 5.697* 0.02251* 0.213; average
Viral infection 0.23 9.232* 0.00248* 0.271; average
Note.
DSG - gallstone disease;
USD - urinary stone disease;
IHD - ischemic heart disease.
Sp - Spearman’s correlation coefficient;
χ2 - criterion for assessing the significance of the difference of the results depending on the risk factor action;
TSFET - two-sided Fisher’s exact test;
φ - the criterion for assessing the strength of the correlation between the risk factor and the result;
* - the difference in the indicator distribution is statistically significant (p<0.05).
References
[1] Apte MV, Pirola RC, Wilson JS. Mechanisms
of alcoholic pancreatitis. J Gastroenterol Hepatol.
2010;25(12):1816–1826. DOI: http://doi.org/
10.1111/j.1440-1746.2010.06445.x
[2] Bala S, Marcos M, Gattu A, Catalano D, Szabo G.
Acute binge drinking increases serum endotoxin and
bacterial DNA levels in healthy individuals. PLoS
One. 2014;9(5):e96864 DOI: http://doi.org/10.
1371/journal.pone.0096864
[3] Chiang CP, Wu CW, Lee SP, Chung CC, Wang
CW, Lee SL, et al. Expression pattern, ethanol-
metabolizing activities, and cellular localization of al-
cohol and aldehyde dehydrogenases in human pan-
creas: implications for pathogenesis of alcohol-
induced pancreatic injury. Alcohol Clin Exp Res.
2009;33(6):1059–1068. DOI: http://doi.org/10.
1111/j.1530-0277.2009.00927.x
[4] Cote GA, Yadav D, Slivka A, Hawes RH, Anderson MA,
Burton FR, et al. Alcohol and smoking as risk factors
in an epidemiology study of patients with chronic pan-
creatitis. Clin Gastroenterol Hepatol. 2011;9(3):266–273.
DOI: http://doi.org/10.1016/j.cgh.2010.
10.015
[5] Ivashchuk SI, Sydorchuk LP. Cholestatic syndrome ac-
tivity in patients with acute edematous pancreatitis and
genes IL-4 (C-590T), TNF-A (G-308A), PRSS1 (R122H)
and CFTR (DELF508C) polymorphism [Published in
Ukrainian]. J Clin Exp Med Res. 2016;4(1):56–64
[6] Law R, Parsi M, Lopez R, Zuccaro G, Stevens T.
Cigarette smoking is independently associated with
chronic pancreatitis. Pancreatol. 2010;10(1):54–59. DOI:
http://doi.org/10.1159/000225927
[7] Lerch MM, Aghdassi AA. The role of bile acids
in gallstone-induced pancreatitis. Gastroenterology.
2010;138(2):429–433. DOI: http://doi.org/10.
1053/j.gastro.2009.12.012
[8] Lugea A, Waldron RT, Pandol SJ. Pancreatic adaptive re-
sponses in alcohol abuse: Role of the unfolded protein re-
sponse. Pancreatol. 2015;15(4 Suppl):S1–5. DOI: http:
//doi.org/10.1016/j.pan.2015.01.011
[9] Maleth J, Balazs A, Pallagi P, Balla Z, Kui B, Ka-
tona M, et al. Alcohol disrupts levels and function of
the cystic fibrosis transmembrane conductance regula-
tor to promote development of pancreatitis. Gastroen-
terol. 2015;148(2):427–439. DOI: http://doi.org/
10.1053/j.gastro.2014.11.002
[10] On approval of standards and clinical protocols
of providing medical care in specialty “Surgery”.
The order of Ministry of Health of Ukraine of
02.04.2010, No 297. [Published in Ukrainian]. Available
from: http://www.moz.gov.ua/ua/portal/
dn_20100402_297.html.
[11] Mustafa A, Begaj I, Deakin M, Durkin D, Cor-
less DJ, Wilson R, et al. Long-term effectiveness of
cholecystectomy and endoscopic sphincterotomy in
the management of gallstone pancreatitis. Surg En-
dosc. 2014;28(1):127–133. DOI: http://doi.org/
10.1007/s00464-013-3138-6
Assessment of Comorbidity as a Risk Factor for Edematous Pancreatitis Considering IL-4 (C-590T) Gene
Polymorphism — 5/5
Table 5. Epidemiological assessment of comorbidities as
risk factors for edematous pancreatitis in T-allele carriers of
the IL-4 gene
Sign GSD USD IHD Viral in-
fection
EER 0.706 0.213 0.152 0.100
CER 0.191 0.469 0.350 0.360
RR 3.686 0.454 0.435 0.277
S (RR) 0.263 0.273 0.380 0.496
95% CI RR 2.199-
6.178
0.266-
0.776
0.206-
0.916
0.105-
0.733
Se 0.400 0.571 0.200 0.114
Sp 0.938 0.187 0.571 0.604
OR 10.133 0.306 0.333 0.197
S (OR) 0.593 0.435 0.473 0.573
95% CI OR 3.167-
32.420
0.131-
0.718
0.132-
0.842
0.064-
0.606
p <0.05 <0.05 <0.05 <0.05
Note.
DSG - gallstone disease;
USD - urinary stone disease;
IHD - ischemic heart disease;
EER - experimental event rate;
CER - control event rate;
RR - relative risk;
S (RR) - standard error of the relative risk;
95% CI RR - 95% confidence interval of the relative risk;
Se - sensitivity;
Sp - specificity;
OR - odds ratio;
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95% CI OR - 95% confidence interval of the odds ratio.
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